The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
May 18th 2011, 3:57pm
A genetic analysis resulted in the discovery of the first predictive biomarker for taxane-induced peripheral neuropathy
May 18th 2011, 2:56pm
Cabozantinib (XL184), an investigational oral tyrosine kinase inhibitor, demonstrated antitumor activity in multiple types of advanced solid tumors.
May 18th 2011, 2:53pm
The risk of dying from ovarian cancer was not reduced when women received CA-125 blood testing and transvaginal ultrasound
May 18th 2011, 2:51pm
A large-scale study of HPV testing and Pap smear for cervical cancer screening confirms that women can safely extend screening intervals from 1 to 3 years.
May 18th 2011, 2:46pm
Prostate-specific antigen (PSA) levels can accurately predict the risk of developing metastasis or death from prostate cancer up to 30 years later
May 18th 2011, 2:37pm
A prospective study analyzed the risk of contracting common cancers based on baseline self-reporting data on smoking, alcohol use, and physical activity
May 18th 2011, 2:33pm
ASCO 2011, June 3-7, 2011 McCormick Place, Chicago, IL
May 7th 2011, 1:27pm
Oncology Nursing Society Congress
Donna Berry on the Distinguished Researcher Award and Her Advice to Researchers
May 7th 2011, 12:43pm
Oncology Nursing Society Congress
Carlton Brown Describes Key Messages of the ONS Congress
May 7th 2011, 11:47am
Oncology Nursing Society Congress
Keynote Presenter Cancer Survivor Charlie Lustman Lives to Tell His Story
May 6th 2011, 1:37pm
Oncology Nursing Society Congress
Susan Moore Oncology Nurse Practitioner/Consultant, MCG Oncology on Adapting a Practice for Use of Oral Oncolytics
May 6th 2011, 1:34pm
Oncology Nursing Society Congress
Oral oncolytics are frequently used in cancer treatment and they make up approximately 25% of the medications in the oncology pipeline
May 6th 2011, 1:21pm
Oncology Nursing Society Congress
Honorary Mistress of Ceremonies Cynthia Nixon kicked off the ONS 36th Annual Congress Cure magazine Extraordinary Healer Award with a rousing tribute
May 6th 2011, 12:59pm
Oncology Nursing Society Congress
Lymphedema is the treatment-induced buildup of extra lymph fluid in tissues that causes discomforting and potentially debilitating swelling of the limbs
May 6th 2011, 12:24pm
Oncology Nursing Society Congress
At ONS researchers from the Seattle Cancer Care Alliance (SCCA) discussed their multidisciplinary care coordination approach for treating patients with Provenge
May 6th 2011, 12:09pm
Oncology Nursing Society Congress
Social media programs allow oncology nurses to network, share information, and learn evidence-based practices
May 6th 2011, 11:54am
Oncology Nursing Society Congress
The FDA recently approved the immunotherapy ipilimumab (Yervoy) as a second-line treatment for patients with metastatic melanoma
May 6th 2011, 7:00am
Oncology Nursing Society Congress
Elizabeth Blasiak on the Significance of the ONS Congress
April 18th 2011, 10:20am
Interdisciplinary Prostate Cancer Congress
Prostate cancer affects 1 of every 6 men in the United States
April 18th 2011, 10:08am
Interdisciplinary Prostate Cancer Congress
Traditional, linear regimen of prostate cancer treatment may need to be reexamined as oncologists learn new ways to incorporate new therapies